editor
human
bocaviru
hbov
newli
describ
parvoviru
pathogen
potenti
clearli
elucid
recent
find
suggest
hbov
may
establish
persist
infect
mucos
lymphocyt
contribut
tonsillar
hyperplasia
children
previou
report
describ
prolong
hbov
dna
detect
immunocompromis
children
partial
sequenc
gene
hbov
bronchoalveolar
lavag
fluid
plasma
sphenoid
sinu
sampl
show
ident
suggest
persist
hbov
strain
period
remain
specul
howev
whether
paranas
sinu
mucosa
repres
site
hbov
persist
clarifi
analyz
sampl
paranas
mucos
tissu
nasal
polyp
patient
chronic
sinus
respiratori
virus
atyp
bacteria
total
tissu
sampl
obtain
patient
median
age
year
rang
year
juli
septemb
elect
surgeri
indic
surgeri
establish
otorhinolaryngologist
common
indic
chronic
sinus
patient
display
acut
respiratori
symptom
time
surgeri
detect
asymptomat
shed
upper
respiratori
tract
viremia
collect
nasal
swab
edtablood
sampl
concurr
studi
protocol
approv
ethic
committe
univers
freiburg
inform
written
consent
obtain
studi
particip
approxim
mg
tissu
specimen
use
nucleic
acid
extract
use
rneasi
mini
kit
describ
qiagen
hamburg
germani
provid
evid
qiagen
rneasi
kit
also
suitabl
dna
extract
spike
hbov
neg
sampl
differ
amount
hbov
dna
extract
nucleic
acid
done
either
qiagen
rneasi
kit
dna
blood
kit
qiagen
extract
nucleic
acid
subject
realtim
pcr
use
primer
specif
hbov
minim
differ
cycl
threshold
ct
valu
hbov
pcr
detect
qiagen
rneasi
kit
therefor
use
throughout
studi
data
shown
nasal
swab
etdablood
purifi
use
qiaamp
minelut
viru
spin
kit
qiagen
multiplex
pcr
respiratori
virus
fasttrack
diagnost
junglinst
luxembourg
conduct
detect
influenza
includ
pandem
b
virus
respiratori
syncyti
viru
human
metapneumoviru
hbov
parainfluenza
viru
human
coronavirus
human
rhinovirus
human
enterovirus
parechovirus
adenovirus
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
bordetella
pertussi
analyz
describ
singl
viru
detect
tissu
specimen
hbov
frequent
follow
rhinoviru
coronaviru
influenza
pandem
viru
hbov
detect
specimen
collect
februari
march
posit
result
confirm
singl
realtim
pcr
patient
differ
mucos
sampl
test
gave
ident
result
multipl
viral
infect
bacteria
detect
median
patient
age
year
rang
year
hbovposit
year
rang
year
hbovneg
sampl
ct
analysi
singl
realtim
pcr
reveal
median
ct
rang
correspond
genom
cell
rang
cell
correl
ct
valu
patient
age
observ
data
shown
underli
diseas
diagnos
hbovposit
patient
wherea
patient
chronic
obstruct
pulmonari
oncolog
diseas
respect
nasal
swab
edtablood
sampl
obtain
hbovposit
patient
respect
hbov
detect
swab
edtablood
sampl
avail
indic
viru
shed
respiratori
tract
viremia
howev
patient
rhinovirusposit
sampl
obtain
biopsi
also
rhinoviru
rna
detect
nasal
swab
suggest
rhinoviru
infect
unfortun
nasal
swab
avail
patient
whose
sinu
biopsi
sampl
posit
hcov
influenza
viru
studi
simultan
analyz
tissu
specimen
paranas
sinus
nasal
polyp
well
nasal
swab
blood
sampl
broad
panel
virus
atyp
bacteria
avoid
season
bia
specimen
collect
period
exclus
obtain
patient
undergo
elect
surgeri
absenc
acut
respiratori
symptom
find
hbov
present
singl
viru
virusposit
biopsi
sampl
intrigu
moreov
fact
hbov
dna
detect
nasal
swab
edtablood
sampl
indic
activ
hbov
infect
previou
studi
hbov
dna
frequent
identifi
adenoid
tonsil
children
howev
contrast
find
detect
hbov
mostli
associ
virus
suggest
cellular
damag
might
contribut
bocaviru
reactiv
replic
find
indic
persist
viral
nucleic
acid
sinu
mucosa
might
special
advantag
hbov
although
relev
observ
remain
unclear
whether
presenc
singl
viru
mean
dead
end
hbov
infect
true
latenc
includ
potenti
reactiv
role
pathogenesi
clinic
condit
requir
surgeri
warrant
futur
studi
